73555-0502 Revuforj - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

73555-0502

Brand Name:

Revuforj

Generic Name:

Revumenib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: REVUMENIB CITRATE

Strength: 160.0

Unit: mg/1

Packages:

Code: 73555-0502-00

Description: 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (73555-502-00)

Effective Date: Nov. 15, 2024

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

KMT2A

Orphan Drug Designation:

Yes

Status:

In Use